NAUTNautilus Biotechnology, Inc.

Nasdaq nautilus.bio


$ 2.60 $ 0.02 (0.78 %)    

Friday, 30-Aug-2024 15:59:50 EDT
QQQ $ 476.00 $ 5.61 (1.19 %)
DIA $ 416.44 $ 2.30 (0.56 %)
SPY $ 563.62 $ 5.33 (0.95 %)
TLT $ 96.60 $ -1.04 (-1.07 %)
GLD $ 231.30 $ -1.66 (-0.71 %)
$ 2.6
$ 2.58 x 200
-- x --
-- - --
$ 2.19 - $ 4.00
47,684
na
326.07M
$ 1.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 10-31-2023 09-30-2023 10-Q
5 08-02-2023 06-30-2023 10-Q
6 05-02-2023 03-31-2023 10-Q
7 02-23-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-02-2022 06-30-2022 10-Q
10 05-03-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-30-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 09-18-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nautilus-biotechnology-q2-eps-014-beats-016-estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

 guggenheim-initiates-coverage-on-nautilus-biotechnology-with-buy-rating-announces-price-target-of-6

Guggenheim analyst Subbu Nambi initiates coverage on Nautilus Biotechnology (NASDAQ:NAUT) with a Buy rating and announces Pr...

 jefferies-assumes-nautilus-biotechnology-at-hold-lowers-price-target-of-3

Jefferies analyst Tycho Peterson assumes Nautilus Biotechnology (NASDAQ:NAUT) with a Hold rating and lowers Price Target of $3.

 nautilus-biotechnology-q1-2024-gaap-eps-015-beats-017-estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate o...

 nautilus-biotechnology-q4-2023-gaap-eps-014-beats-015-estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-february-28-2024

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings at $0.08 per share on revenu...

 nautilus-biotechnology-q3-eps-013-beats-017-estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate o...

 earnings-scheduled-for-october-31-2023

Companies Reporting Before The Bell • BBVA (NYSE:BBVA) is likely to report earnings for its third quarter. • BP (NYSE:BP) is ...

 williams-sonoma-ess-tech-and-other-big-stocks-moving-higher-on-monday

U.S. stocks traded lower, with the Dow Jones falling around 100 points on Monday. Here are some big stocks recording gains in t...

 farfetch-faraday-future-intelligent-electric-vinfast-and-other-stocks-moving-lower-on-friday

U.S. stocks traded down this morning, with the Nasdaq Composite falling more than 101 points on Friday. Here are some big stock...

 us-stocks-sink-deere-shares-fall-despite-earnings-beat

U.S. stocks traded down this morning with the Nasdaq Composite falling more than 101 points on Friday. The Dow traded down 0.2...

 morgan-stanley-reiterates-equal-weight-on-nautilus-biotechnology-maintains-6-price-target

Morgan Stanley analyst Tejas Savant reiterates Nautilus Biotechnology (NASDAQ:NAUT) with a Equal-Weight and maintains $6 pri...

 earnings-scheduled-for-august-2-2023

Companies Reporting Before The Bell • Vanguard Extended Duration Treasury ETF (NYSE:EDV) is estimated to report quarterly earn...

 nautilus-biotechnology-q2-eps-013-beats-017-estimate

Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate o...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION